Abiopharma

Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026

Equity Residential and AvalonBay Announce Vivmark Residential as Name of Combined Company

Johnson & Johnson's RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

IperionX – June 2026 Quarterly Report

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

VenHub Highlights Proprietary AI, Robotics and Autonomous Retail Technology, Smart Store Expansion and Growth Pipeline

InterDigital Announces Financial Results for Second Quarter 2026

The Arena Group and I-dentity Group Unveil the “Travel Adventure Network” and First Resort Property in Cap Cana, Dominican Republic

York Space Systems to Release Second Quarter 2026 Results on August 13, 2026